Many researchers reported that, as the main type of natural killer cells, CD56 bright natural killer cell mainly played a role in inhibiting the T-cell signaling pathway in the disease progression of MS (32–34), thereby reducing its damage to the brain. This evidence concerns the gene NCAM1 and myeloid sarcoma.